Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and ...

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

Martin A. Makary, MD, of Johns Hopkins University, a critic of vaccination schedules and COVID-19 measures promulgated by ...

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.

A new approach for identifying new cellular RNA targets of snoRNAs uncovered thousands of previously unknown targets ...

Researchers have mapped the activity of repair proteins in individual human cells. The study demonstrates how these proteins ...

Lipid nanoparticles made from lipids optimized via directed chemical evolution show high performance as mRNA delivery vehicles.

Novartis has acquired Kate Therapeutics for up to $1.1 billion, the companies said today, in a deal that expands the buyer’s ...

Researchers suggest broadly reactive antibodies identified are likely to represent a common mechanism of acquired immunity to ...

The NATi mRNA BioFoundry is part of an ongoing effort to strengthen Singapore’s position in nucleic acid therapeutics.

The new business combines solutions from four companies and will target customers in pharma and biotech, consumer markets, ...

Shares of several COVID-19 vaccine developers sank fast enough to reflect investor jitters about vaccine policy given RFK’s ...